Tuesday, November 28, 2023
More

    Corona virus: Antibodies against Covid-19 in two out of five in Srinagar, sero-survey reveals


    Srinagar. Recently, a government hospital survey found that 40 percent of the population of Jammu and Kashmir’s Srinagar district developed Covid 19 antibodies. A new sero-spread survey indicates that a large section of the population of the capital of Jammu and Kashmir has been infected with the corona virus. Jammu and Kashmir has reported nearly 85,000 Covid-19 cases and 1455 deaths.

    Results of a survey conducted by the Government Medical College (GMC), Srinagar showed a 3.8 percent increase in sero-predominance in the city compared to a similar survey conducted in June. In sero-survey, the person’s blood serum is tested, which shows antibodies in the body against the infection.

    “We did a sero-survey in Srinagar district, which showed that 40 per cent of the 2,400 people were not confirmed infected but developed antibodies,” said Dr Mohammad Salim Khan, Head of Community Medicine, GMC Srinagar. Khan said that samples were taken randomly from 20 clusters in Srinagar. It has also been found that women have more antibodies than men. He said, ‘This trend is encouraging, but it does not mean that we can say that Covid-19 can be defeated if a certain level of antibody is developed in the population.’

    348 people have died in Srinagar district so far

    The worst affected district of Jammu and Kashmir is Srinagar. About 19,000 people have been infected and 348 have died. 1651 patients are undergoing treatment in the district and 195300 affected patients are undergoing treatment in other districts. Khan said that a large-scale sero survey is being conducted in nine other districts of the Kashmir Valley and 400 samples have been taken from each district. He said that the results are expected to be published within two weeks.

    Tag: Antibodies, Corona virus, Jammu and Kashmir, sero survey, Srinagar

    Related Articles

    LEAVE A REPLY

    Please enter your comment!
    Please enter your name here

    Most Popular